Usana Health Sciences (USNA) Receivables - Other (2011 - 2026)

Usana Health Sciences (USNA) has 13 years of Receivables - Other data on file, last reported at $8.1 million in Q1 2026.

• On a quarterly basis, Receivables - Other rose 9.03% year-over-year to $8.1 million in Q1 2026; TTM through Jan 2026 was $8.1 million, a 9.03% increase from a year earlier, with the FY2026 full-year figure at $8.1 million, up 9.03% from the prior year.
• Receivables - Other for Q1 2026 stood at $8.1 million, up from $7.4 million in the prior quarter.
• Over the last five years, Receivables - Other for USNA reached as high as $8.1 million in Q1 2026 and fell as low as $5.2 million in Q4 2022.
• Historically, Receivables - Other has averaged $6.5 million across 4 years, with a median of $6.2 million in 2023.
• Across the five-year window, Receivables - Other decreased 10.68% in 2022 and rose 20.2% in 2024, its largest moves.
• Year by year, Receivables - Other stood at $5.2 million in 2022, then increased by 19.08% to $6.2 million in 2023, then advanced by 20.2% to $7.4 million in 2024, then increased by 9.03% to $8.1 million in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $8.1 million in Q1 2026, $7.4 million in Q4 2024, and $6.2 million in Q4 2023.